Amanda L. Hudson
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey.
Journal: Neuro-oncology practice
Published: October 13, 2025
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours.
Journal: Journal of neuro-oncology
Published: September 02, 2025
A protocol for pre-treatment testing for antibodies to galactose-alpha-1,3-galactose to mitigate the risk of cetuximab hypersensitivity reactions - a retrospective cohort review.
Journal: Cancer treatment and research communications
Published: April 10, 2025
CA9, CYFIP2 and LGALS3BP-A Novel Biomarker Panel to Aid Prognostication in Glioma.
Journal: Cancers
Published: January 15, 2024
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer.
Journal: Journal of cancer research and clinical oncology
Published: June 10, 2023
CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review.
Journal: Current issues in molecular biology
Published: May 31, 2023
PSMA Expression Correlates with Improved Overall Survival and VEGF Expression in Glioblastoma.
Journal: Biomedicines
Published: March 16, 2023
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer.
Journal: Journal of clinical medicine
Published: January 13, 2023
Differential effects of radiation fractionation regimens on glioblastoma.
Journal: Radiation oncology (London, England)
Published: August 12, 2021
Last Updated: 09/26/2026